SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

Arcturus Therapeutics Q1 EPS $(0.670) Misses $(0.610) Estimate, Sales $2.600M Miss $4.970M Estimate

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.670) per share which missed the analyst consensus estimate of $(0.610) by 9.84 percent. The company reported quarterly sales of $2.600 million which

Benzinga · 05/07/2020 20:29

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.670) per share which missed the analyst consensus estimate of $(0.610) by 9.84 percent. The company reported quarterly sales of $2.600 million which missed the analyst consensus estimate of $4.970 million by 47.69 percent.